معرفی
Peter Lindgren is an Adjunct Professor at the Department of Learning, Informatics, Management and Ethics at Karolinska Institutet in Sweden. His research focuses on health economics, pharmacoeconomics, and health technology assessment, with extensive work on chronic diseases such as cancer, cardiovascular disease, and rare disorders. He holds a part-time position and is actively involved in international research collaborations.
Research Interests:
- Health economics and pharmacoeconomics
- Cost-effectiveness analysis of medical interventions
- Health technology assessment
- Burden of disease studies
- Real-world evidence and health policy
- Precision medicine economics
- Rare disease economics
Recent Research Trends: Lindgren's recent work spans across multiple high-impact areas including the integration of resource constraints in health economic evaluations, societal costs of rare diseases like arginase 1 deficiency, and the global value of precision medicine in oncology. His research often involves multinational collaborations and addresses pressing health policy questions, particularly in Europe and globally.
Scientific Contributions: While no specific awards are listed, Lindgren's extensive publication record in top-tier journals like Value in Health, PharmacoEconomics, and European Journal of Health Economics underscores his significant contributions to the field. His work frequently informs health policy and clinical practice guidelines.
Collaborations and Teams: He collaborates with numerous international consortia such as the PIONEER consortium for prostate cancer research and the IHI-PROMINENT project for neurodegeneration. His work often involves cross-disciplinary teams including clinicians, economists, and policymakers.
